Group | Risk factors | Level of risk | Allergy evaluation for CM |
---|---|---|---|
0 | Female gender [19] Atopy [19] Intravascular CM injection [23] Severe cardiovascular disease [23] Viral infection and autoimmune diseases [1] Psychiatric disorders [23] Interleukin-2 treatment and contact allergy (for NIHRs) [2] Treatment with ACE-inhibitors, beta-blockers, or proton pump inhibitors (for IHRS) [19] Food allergy [23] Drug allergy [24] Concomitant allergic disease [23] Allergy to iodine-containing antiseptics [25] | Very low (not relevant) | No |
1 | Active urticaria-angioedema [2, 22] Mastocytosis [19] Recurrent angioedema Idiopathic anaphylaxis | Medium | No |
2 | History of hypersensitivity reactions to contrast media of the same class of the one to be administered [1, 7, 17, 18, 20] | High | Yes |